直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Federal Circuit Split over “Plainly Dissimilar” Design, Affirms Summary Judgement of Non-infringement

February 24, 2026

Authored and Edited by Erik R. Puknys; Wyatt L. Bazrod; *Xu Wang

In Range of Motion Prods., LLC v. Armaid Company Inc., No. 2023-2427 (Fed. Cir. Feb 2, 2026), the Federal Circuit affirmed the district court’s grant of summary judgment of non-infringement in favor of Armaid.  

Range of Motion Products (“RoM”) accused Armaid of infringing Design Patent No. D802,155 (the “D’155 patent”), which claims the ornamental design for a body massaging apparatus. After construing the claim to its ornamental elements, the district court concluded that no reasonable jury could find the design of the accused product substantially similar to the claimed design. RoM timely appealed.  

RoM argued that, even under the district court’s claim construction, the accused product is similar enough to the claimed design to withstand summary judgment. The majority rejected this argument, emphasizing that a proper “ordinary observer” test under Egyptian Goddess includes examining whether the claimed and accused designs are “sufficiently distinct” and “plainly dissimilar.” Applying this test, the majority affirmed the district court’s summary judgment of non-infringement. 

Chief Judge Moore dissented, noting how the Court’s decision in Egyptian Goddess unwittingly “changed the frame of reference” of the ordinary observer test from whether two designs are substantially similar to whether two designs are plainly dissimilar. Chief Judge Moore illustrated how the outcome may change depending on whether the fact finder focuses on differences rather than the overall similarity of the claimed and accused designs.  She noted that this was not an isolated incident, but part of a much broader trend. 

 

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Prosecution and Portfolio Management

Design Rights

Related Industries

Consumer Goods and Services

Consumer Products

Hospitality, Gaming, and Leisure

Sports, Fitness, and Outdoor Recreation

Related Offices

Atlanta, GA

Palo Alto, CA

Contacts

Erik R. Puknys
Partner
Palo Alto, CA
+1 650 849 6644
Email
Wyatt L. Bazrod
Associate
Atlanta, GA
+1 404 653 6518
Email

*Xu Wang is a Law Clerk at Finnegan. 

Copyright © 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Articles

COPPA’s Amended Rule Is Now in Full Effect: What Operators Need to Know

May 15, 2026

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP